Brief: Samsung Pharmaceutical Plans 20 Bln Won Investment In S.Korea
26/12/2018 24:37
Dec 26 (Reuters) - Samsung Pharmaceutical Co Ltd
001360.KS :
* SAYS PLANS 20 BILLION WON ($17.75 million) WORTH
INVESTMENT TO
BUILD NEW PRODUCTION LINE IN S.KOREA
* AIMS TO START PRODUCTION IN JAN 2020
Source text for Eikon: https://bit.ly/2EPEYkp
Further company coverage: 001360.KS
($1 = 1,126.7000 won)
((Reuters Messaging: joori.roh.thomsonreuters.com@reuters.net))
Recent news on Samsung Pharm
See all newsBrief: Samsung Pharmaceutical Wins 33.5 Billion Won Order
Brief: Samsung Pharmaceutical Says Acquires Shares Worth 12.5 bln Won In True Life Insurance Bank
Brief: Samsung Pharmaceutical To Invest 15.3 Billion Won To Build New Manufacturing Line
Brief: Samsung Pharmaceutical To Sell 8 Bln Won Asset To Samsung Medicos
Brief: Samsung Pharmaceutical Plans 20 Bln Won Investment In S.Korea